432 related articles for article (PubMed ID: 22460183)
21. Corticosteroid effectiveness in IgA nephropathy: long-term results of a randomized, controlled trial.
Pozzi C; Andrulli S; Del Vecchio L; Melis P; Fogazzi GB; Altieri P; Ponticelli C; Locatelli F
J Am Soc Nephrol; 2004 Jan; 15(1):157-63. PubMed ID: 14694168
[TBL] [Abstract][Full Text] [Related]
22. [Management of IgA nephropathy].
Amoroso L; De Sanctis L; Cappelli P; Di Vito R; Sirolli V; Bonomini M
G Ital Nefrol; 2011; 28(6):622-32. PubMed ID: 22167613
[TBL] [Abstract][Full Text] [Related]
23. Corticosteroids could improve the renal outcome of IgA nephropathy with moderate proteinuria.
Zhong Z; Tang Y; Tan J; Tan L; Pei G; Qin W
Int Urol Nephrol; 2021 Jan; 53(1):121-127. PubMed ID: 32944888
[TBL] [Abstract][Full Text] [Related]
24. Long-term renal survival and related risk factors in patients with IgA nephropathy: results from a cohort of 1155 cases in a Chinese adult population.
Le W; Liang S; Hu Y; Deng K; Bao H; Zeng C; Liu Z
Nephrol Dial Transplant; 2012 Apr; 27(4):1479-85. PubMed ID: 21965586
[TBL] [Abstract][Full Text] [Related]
25. Cytotoxic therapy for membranous nephropathy and renal insufficiency: improved renal survival but high relapse rate.
du Buf-Vereijken PW; Branten AJ; Wetzels JF;
Nephrol Dial Transplant; 2004 May; 19(5):1142-8. PubMed ID: 14993502
[TBL] [Abstract][Full Text] [Related]
26. Changes in Proteinuria and Side Effects of Corticosteroids Alone or in Combination with Azathioprine at Different Stages of IgA Nephropathy.
Sarcina C; Tinelli C; Ferrario F; Pani A; De Silvestri A; Scaini P; Del Vecchio L; Alberghini E; Buzzi L; Baragetti I; Pozzi C
Clin J Am Soc Nephrol; 2016 Jun; 11(6):973-981. PubMed ID: 27129712
[TBL] [Abstract][Full Text] [Related]
27. Short- and long-term efficacy of oral cyclophosphamide and steroids in patients with membranous nephropathy and renal insufficiency. Study Group.
Branten AJ; Wetzels JF
Clin Nephrol; 2001 Jul; 56(1):1-9. PubMed ID: 11499653
[TBL] [Abstract][Full Text] [Related]
28. Behcet's disease and IgA nephropathy: report of this association in a patient from Brazil and literature review.
Fernandes PF; Júnior GB; Barros FA; Sousa DC; Franco LM; Patrocínio RM
Invest Clin; 2006 Dec; 47(4):405-11. PubMed ID: 17176908
[TBL] [Abstract][Full Text] [Related]
29. IgACE: a placebo-controlled, randomized trial of angiotensin-converting enzyme inhibitors in children and young people with IgA nephropathy and moderate proteinuria.
Coppo R; Peruzzi L; Amore A; Piccoli A; Cochat P; Stone R; Kirschstein M; Linné T
J Am Soc Nephrol; 2007 Jun; 18(6):1880-8. PubMed ID: 17513327
[TBL] [Abstract][Full Text] [Related]
30. Azathioprine/methylprednisolone versus cyclophosphamide in proliferative lupus nephritis. A randomized controlled trial.
Grootscholten C; Ligtenberg G; Hagen EC; van den Wall Bake AW; de Glas-Vos JW; Bijl M; Assmann KJ; Bruijn JA; Weening JJ; van Houwelingen HC; Derksen RH; Berden JH;
Kidney Int; 2006 Aug; 70(4):732-42. PubMed ID: 16820790
[TBL] [Abstract][Full Text] [Related]
31. Natural history of immunoglobulin A nephropathy and predictive factors of prognosis: a long-term follow up of 204 cases in China.
Lv J; Zhang H; Zhou Y; Li G; Zou W; Wang H
Nephrology (Carlton); 2008 Jun; 13(3):242-6. PubMed ID: 18221258
[TBL] [Abstract][Full Text] [Related]
32. A novel simpler histological classification for renal survival in IgA nephropathy: a retrospective study.
Manno C; Strippoli GF; D'Altri C; Torres D; Rossini M; Schena FP
Am J Kidney Dis; 2007 Jun; 49(6):763-75. PubMed ID: 17533019
[TBL] [Abstract][Full Text] [Related]
33. Steroid and cyclophosphamide in IgA nephropathy.
Roccatello D; Ferro M; Cesano G; Rossi D; Berutti S; Salomone M; Piccoli G; Sena LM
Nephrol Dial Transplant; 2000 Jun; 15(6):833-5. PubMed ID: 10831636
[TBL] [Abstract][Full Text] [Related]
34. Role of proteinuria reduction in the progression of IgA nephropathy.
Locatelli F; Pozzi C; Del Vecchio L; Bolasco PG; Fogazzi GB; Andrulli S; Melis P; Altieri P; Ponticelli C
Ren Fail; 2001; 23(3-4):495-505. PubMed ID: 11499564
[TBL] [Abstract][Full Text] [Related]
35. Tonsillectomy and steroid pulse therapy significantly impact on clinical remission in patients with IgA nephropathy.
Hotta O; Miyazaki M; Furuta T; Tomioka S; Chiba S; Horigome I; Abe K; Taguma Y
Am J Kidney Dis; 2001 Oct; 38(4):736-43. PubMed ID: 11576876
[TBL] [Abstract][Full Text] [Related]
36. Long-term results of a randomized controlled trial in childhood IgA nephropathy.
Kamei K; Nakanishi K; Ito S; Saito M; Sako M; Ishikura K; Hataya H; Honda M; Iijima K; Yoshikawa N;
Clin J Am Soc Nephrol; 2011 Jun; 6(6):1301-7. PubMed ID: 21493743
[TBL] [Abstract][Full Text] [Related]
37. Long-term follow-up of a randomised controlled trial of azathioprine/methylprednisolone versus cyclophosphamide in patients with proliferative lupus nephritis.
Arends S; Grootscholten C; Derksen RH; Berger SP; de Sévaux RG; Voskuyl AE; Bijl M; Berden JH;
Ann Rheum Dis; 2012 Jun; 71(6):966-73. PubMed ID: 22128082
[TBL] [Abstract][Full Text] [Related]
38. Treatment with cyclophosphamide delays the progression of chronic lesions more effectively than does treatment with azathioprine plus methylprednisolone in patients with proliferative lupus nephritis.
Grootscholten C; Bajema IM; Florquin S; Steenbergen EJ; Peutz-Kootstra CJ; Goldschmeding R; Bijl M; Hagen EC; Van Houwelingen HC; Derksen RH; Berden JH;
Arthritis Rheum; 2007 Mar; 56(3):924-37. PubMed ID: 17328070
[TBL] [Abstract][Full Text] [Related]
39. The effectiveness of steroid therapy for patients with advanced IgA nephropathy and impaired renal function.
Moriyama T; Honda K; Nitta K; Yumura W; Nihei H
Clin Exp Nephrol; 2004 Sep; 8(3):237-42. PubMed ID: 15480901
[TBL] [Abstract][Full Text] [Related]
40. Strict blood-pressure control and progression of renal failure in children.
; Wühl E; Trivelli A; Picca S; Litwin M; Peco-Antic A; Zurowska A; Testa S; Jankauskiene A; Emre S; Caldas-Afonso A; Anarat A; Niaudet P; Mir S; Bakkaloglu A; Enke B; Montini G; Wingen AM; Sallay P; Jeck N; Berg U; Caliskan S; Wygoda S; Hohbach-Hohenfellner K; Dusek J; Urasinski T; Arbeiter K; Neuhaus T; Gellermann J; Drozdz D; Fischbach M; Möller K; Wigger M; Peruzzi L; Mehls O; Schaefer F
N Engl J Med; 2009 Oct; 361(17):1639-50. PubMed ID: 19846849
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
